{"id":6370,"date":"2026-02-19T14:19:30","date_gmt":"2026-02-19T14:19:30","guid":{"rendered":"https:\/\/www.paytmmoney.com\/blog\/?p=6370"},"modified":"2026-02-20T04:10:12","modified_gmt":"2026-02-20T04:10:12","slug":"gaudium-ivf-women-health-ipo-review","status":"publish","type":"post","link":"https:\/\/www.paytmmoney.com\/blog\/gaudium-ivf-women-health-ipo-review\/","title":{"rendered":"Gaudium IVF & Women Health IPO Review: Key Details, Company Overview, Industry Context & Financials"},"content":{"rendered":"

Gaudium IVF & Women Health IPO is a book-built public issue with a total size of approximately \u20b9165 crore, comprising both a fresh issue and an offer-for-sale component. The issue includes a fresh issue of 1,13,92,500 equity shares and an Offer For Sale (OFS) of 94,93,700 equity shares by the promoter.<\/span><\/p>\n

The IPO subscription window opened on February 20, 2026 and closed on February 24, 2026. The basis of allotment was likely finalised on February 25, 2026, and the shares are expected to list on both BSE and NSE on February 27, 2026, subject to final approvals.<\/span><\/p>\n

The IPO price band is fixed at \u20b975 to \u20b979 per equity share. Investors must apply in a lot size of 189 shares, with retail investors needing to invest a minimum amount of \u20b914,931 at the upper band (\u20b979). Retail maximum, S-HNI and B-HNI investment brackets vary by lot size.<\/span><\/p>\n

Smart Horizon Capital Advisors is the Book Running Lead Manager, and <\/span>Bigshare Services Pvt. Ltd.<\/span><\/a> is the Registrar of the IPO.<\/span><\/p>\n

(<\/span><\/i>Source:<\/i><\/b> RHP<\/span><\/i><\/a>)<\/span><\/i><\/span><\/p>\n

Company Overview<\/b><\/h2>\n

Gaudium IVF & Women Health Limited is a fertility and women\u2019s healthcare services provider offering in-vitro fertilisation (IVF), advanced assisted reproductive technologies (ART) and related clinical care. It operates a hub-and-spoke model with 7 full-service IVF hubs and 28 spokes across India, supporting strong geographic reach and patient access. The hub-and-spoke model is a system of connections designed like a bicycle wheel, where all traffic or data moves through a central point (the hub) before being distributed to individual branches (the spokes).<\/span><\/p>\n

The company provides services such as In Vitro Fertilisation (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), ovulation induction, male infertility treatments, fertility preservation procedures, and comprehensive women\u2019s health care. It also attracts international patients from regions including the UK, USA, Canada, Kenya, South Africa, and Oman.<\/span><\/p>\n

(<\/span><\/i>Source:<\/i><\/b> RHP<\/span><\/i><\/a>)<\/span><\/i><\/span><\/p>\n

Industry Context<\/b><\/h2>\n